• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchCEL-SCI
    Picture of CEL-SCI logo

    CVM — CEL-SCI Share News

    $1.110.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      $19.40m
    • Enterprise Value
      $24.35m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • CVM Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    CVM Dividends
    • AMEX HALT ADDITIONAL INFORMATION LAST 31.900000

      27/01/2021 16:47
    • Amex Resumed Cel: SCI CORP ORD

      27/01/2021 16:46
    • AMEX HALT ADDITIONAL INFORMATION LAST 31.900000

      27/01/2021 16:41
    • Amex Resumed Cel: SCI CORP ORD

      27/01/2021 16:41
    • AMEX HALT ADDITIONAL INFORMATION LAST 34.100000

      27/01/2021 16:36
    • Amex Resumed Cel: SCI CORP ORD

      27/01/2021 16:35
    • AMEX HALT ADDITIONAL INFORMATION LAST 33.940000

      27/01/2021 16:30
    • Amex Resumed Cel: SCI CORP ORD

      27/01/2021 16:28
    • AMEX HALT ADDITIONAL INFORMATION LAST 27.250000

      27/01/2021 16:23
    • Amex Resumed Cel: SCI CORP ORD

      27/01/2021 16:20
    • AMEX HALT ADDITIONAL INFORMATION LAST 22.040000

      27/01/2021 16:15
    • Amex Resumed Cel: SCI CORP ORD

      27/01/2021 16:14
    • AMEX HALT ADDITIONAL INFORMATION LAST 19.840000

      27/01/2021 16:09
    • Brief: Cel-Sci Says Financial Statements Within Quarterly Reports For Quarter Ended Dec 31, 2019, March 31, 2020, & June 30, 2020 Should Not Be Relied Upon

      29/12/2020 22:06
    • Brief: CEL-SCI Announces Update On Phase 3 Cancer Trial Results

      07/12/2020 14:23
    • Brief: CEL-SCI Says Awarded European Patent For LEAPS Vaccine In Treatment Of Rheumatoid Arthritis

      18/09/2020 14:48
    • Brief: Cel-Sci Corporation Reports Qtrly Loss Per Share Of $0.27

      11/08/2020 15:49
    • Brief: CEL-SCI Posts Qtrly Loss Per Share $0.68

      11/08/2020 13:54
    • Brief: Cel-Sci Announces Early Results With Covid 19 Leaps Vaccine/Treatment

      24/07/2020 13:39
    • Brief: CEL-SCI Corporation Receives $10 Million Through Warrant Exercises

      30/06/2020 13:45
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.